243 related articles for article (PubMed ID: 35579442)
1. Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.
Badiee P; Boekhout T; Zarei Mahmoudabadi A; Mohammadi R; Ayatollahi Mousavi SA; Najafzadeh MJ; Soltani J; Hashemi J; Diba K; Ghadimi-Moghadam A; Salimi-Khorashad AR; Shokohi T; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Jun; 10(3):e0253921. PubMed ID: 35579442
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity.
Pfaller MA; Carvalhaes CG; Castanheira M
Mycoses; 2023 Oct; 66(10):854-868. PubMed ID: 37431241
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
5. Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Gharaghani M; Taghipour S; Zarei Mahmoudabadi A
Mol Biol Rep; 2020 Nov; 47(11):8903-8909. PubMed ID: 33130966
[TBL] [Abstract][Full Text] [Related]
6. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of
Nargesi S; Jafarzadeh J; Najafzadeh MJ; Nouripour-Sisakht S; Haghani I; Abastabar M; Ilkit M; Hedayati MT
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451946
[No Abstract] [Full Text] [Related]
7. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
[TBL] [Abstract][Full Text] [Related]
8. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.
Wang HC; Hsieh MI; Choi PC; Wu WL; Wu CJ;
Mycoses; 2023 Aug; 66(8):711-722. PubMed ID: 37186489
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
Kachuei R; Khodavaisy S; Rezaie S; Sharifynia S
J Mycol Med; 2016 Mar; 26(1):17-21. PubMed ID: 26852191
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
11. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
[TBL] [Abstract][Full Text] [Related]
13. Species Distribution and Antifungal Susceptibilities of
Badali H; Cañete-Gibas C; McCarthy D; Patterson H; Sanders C; David MP; Mele J; Fan H; Wiederhold NP
J Clin Microbiol; 2022 May; 60(5):e0028022. PubMed ID: 35400175
[No Abstract] [Full Text] [Related]
14. Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two
Lyskova P; Hubka V; Svobodova L; Barrs V; Dhand NK; Yaguchi T; Matsuzawa T; Horie Y; Kolarik M; Dobias R; Hamal P
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437620
[TBL] [Abstract][Full Text] [Related]
15. Aspergillus Species Causing Invasive Fungal Disease in Queensland, Australia.
Stewart AG; Isler B; Simos P; Farquhar D; George N; Golmayo M; Heney C
Mycopathologia; 2023 Jun; 188(3):211-219. PubMed ID: 37067664
[TBL] [Abstract][Full Text] [Related]
16. Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Halvaeezadeh M; Jalaee GA; Fatahinia M; Mahmoudabadi AZ
Microb Pathog; 2023 Aug; 181():106180. PubMed ID: 37257666
[TBL] [Abstract][Full Text] [Related]
17. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
[TBL] [Abstract][Full Text] [Related]
18. The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of
Djenontin E; Costa JM; Mousavi B; Nguyen LDN; Guillot J; Delhaes L; Botterel F; Dannaoui E
Microorganisms; 2023 Sep; 11(10):. PubMed ID: 37894087
[TBL] [Abstract][Full Text] [Related]
19. In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis.
Omran SM; Taghizadeh-Armaki M; Zarrinfar H; Hedayati MT; Abastabar M; Moqarabzadeh V; Ansari S; Saber S; Hoseinnejad A; Miri A; Verweij PE; Seyedmousavi S
J Infect Chemother; 2019 Feb; 25(2):157-160. PubMed ID: 30241879
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Badiee P; Shokohi T; Hashemi J; Mohammadi R; Najafzadeh MJ; Amin Shahidi M; Ghasemi F; Jafarian H
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):15. PubMed ID: 36805670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
